Boston Medical Center is an international referral center for the diagnosis and treatment of amyloidosis, a rare group of diseases caused by the abnormal accumulation of the protein amyloid in various parts of the body. This can occur as part of a bone marrow plasma cell disorder (AL), as a hereditary form (AF), an age-related form (senile systemic amyloidosis due to ATTR), or secondary to chronic inflammatory or infectious diseases (AA).
The Amyloidosis Center at BMC offers a multi-disciplinary approach to diagnosis and treatment of this multi-organ disorder.
Specialists in hematology-oncology, cardiology, pulmonary medicine, nephrology, gastroenterology, neurology, otolaryngology, urology, and radiation oncology coordinate to evaluate patients and develop care plans.
Amyloidosis frequently involves more than one organ system. For this reason, the Amyloidosis Center offers a multispecialty evaluation for patients. This is a three day, outpatient evaluation comprised of a number of tests and consultations which will help determine the amyloid type and organ system involvement. Patients are guided through each step of the evaluation, with doctors and nurses explaining why each test is being done and what the results mean.
Once the evaluation is complete, a treatment plan is developed.
Medical and pathological consultation services are also available to patients and doctors.
Please visit Boston University School of Medicine’s Amyloidosis Center website for more information about the types of amyloidosis, the patient evaluation process, and consultation services.